Literature DB >> 33457136

Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.

Muhammad Hussain1, Rajesh Kumar2, Ali Ammar2, Syed Alishan2, Atif S Muhammad2, Fawad Farooq3, Tahir Saghir3, Naveedullah Khan2, Syed N Hassan Rizvi4,1, Tariq Ashraf3.   

Abstract

Background ST elevation myocardial infarction (STEMI) is classically characterized by total occlusion of the culprit coronary artery. However during primary percutaneous coronary intervention (PCI) thrombolysis in myocardial infarction (TIMI) 0 flow is not observed in all patients' culprit arteries in angiographic views. This study was conducted to find out the frequency of TIMI flow in acute STEMI patients in view of the above concept. The aim of this study was to evaluate the frequency of pre-procedural TIMI III flow in those patients who underwent primary PCI for acute STEMI in a public sector hospital in Karachi, Pakistan. Methodology This study is an audit of already saved data in the catheterization laboratory of the National Institute of Cardiovascular Diseases (NICVD), Karachi, that was collected prospectively from January 2016 to December 2018. These data were collected after taking consent from those patients who presented to hospital within 12 hours of symptoms and underwent primary PCI. Data were entered and analyzed on Statistical Package for the Social Sciences (SPSS) version 19 (IBM Corp., Armonk, NY, USA). Results A total of 8018 patients were included in this study who presented with STEMI and underwent primary PCI. Out of them 80.9% were males. Hypertension was the leading risk factor in 54.1% (4340) of patients. TIMI III flow was present in 11.4% of patients before primary PCI, while TIMI 0, I and II flow were present in 57.1%, 15.1%, and 16.3% of patients respectively (p<0.001). Fourteen percent of patients with TIMI III flow were of age group 51 to 60 years. Among those who had TIMI III flow, 11.2% were those with door to balloon time of <90 minutes. In 11% of cases, left anterior descending (LAD) artery had TIMI III flow as compared to other vessels (p<0.001). The length of the lesion was significantly smaller in patients who had TIMI III flow compared to those who had TIMI 0-II flow. Conclusions This study revealed that not all patients with acute STEMI had totally occluded culprit coronary artery but some of them had angiographic TIMI I-III flow in the infarct-related artery. Further studies are needed to find the reason for re-establishment of flow in the culprit vessel in STEMI patients before PCI.
Copyright © 2020, Hussain et al.

Entities:  

Keywords:  coronary artery disease; infarct related artery; primary percutaneous coronary intervention; spontaneous revascularization; st elevation myocardial infarction; thrombolysis in myocardial infarction; vessel patency

Year:  2020        PMID: 33457136      PMCID: PMC7797447          DOI: 10.7759/cureus.12036

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  27 in total

1.  System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).

Authors:  Peter H Nielsen; Christian J Terkelsen; Torsten T Nielsen; Leif Thuesen; Lars R Krusell; Per Thayssen; Henning Kelbaek; Ulrik Abildgaard; Anton B Villadsen; Henning R Andersen; Michael Maeng
Journal:  Am J Cardiol       Date:  2011-07-15       Impact factor: 2.778

2.  Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.

Authors:  Gregg W Stone; Harry P Selker; Holger Thiele; Manesh R Patel; James E Udelson; E Magnus Ohman; Akiko Maehara; Ingo Eitel; Christopher B Granger; Paul L Jenkins; Melissa Nichols; Ori Ben-Yehuda
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

3.  Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.

Authors:  Christos Christopoulos; Mohamed Farag; Keith Sullivan; David Wellsted; Diana A Gorog
Journal:  Thromb Haemost       Date:  2015-12-22       Impact factor: 5.249

4.  Left Circumflex Coronary Artery as the Culprit Vessel in ST-Segment-Elevation Myocardial Infarction.

Authors:  Diab Ghanim; Fabio Kusniec; Wadi Kinany; Dahud Qarawani; David Meerkin; Khaled Taha; Offer Amir; Shemy Carasso
Journal:  Tex Heart Inst J       Date:  2017-10-01

5.  Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials.

Authors:  G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

Review 6.  Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?

Authors:  Patrícia O Guimarães; Pierluigi Tricoci
Journal:  Expert Opin Pharmacother       Date:  2015-07-29       Impact factor: 3.889

7.  Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction.

Authors:  Paul Fefer; Hanoch Hod; Haim Hammerman; Valentina Boyko; Shlomo Behar; Shlomi Matetzky
Journal:  Am J Cardiol       Date:  2008-11-06       Impact factor: 2.778

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

9.  Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.

Authors:  Mohamed Farag; Nikolaos Spinthakis; Ying X Gue; Manivannan Srinivasan; Keith Sullivan; David Wellsted; Diana A Gorog
Journal:  Eur Heart J       Date:  2019-01-14       Impact factor: 29.983

10.  Influence of angiographic spontaneous coronary reperfusion on long-term prognosis in patients with ST-segment elevation myocardial infarction.

Authors:  Xiaoming Li; Boyu Li; Jing Gao; Yunfei Wang; Song Xue; Dachuan Jiang; Qi Hua; Jing Li
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.